SCHEMBL6507964

SCHEMBL6507964

Cc1cccc(NC(N)=Nc2cccc(Cc3ccccc3)c2)c1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 18/20 0.72
GRIN2D O15399 6/20 0.72
GRIN3B O60391 6/20 0.72
GRIN1 Q05586 6/20 0.72
GRIN2A Q12879 6/20 0.72
GRIN2B Q13224 6/20 0.72
GRIN2C Q14957 6/20 0.72
GRIN3A Q8TCU5 6/20 0.72
CYP2D6 P10635 2/20 0.52
CYP1A2 P05177 1/20 0.52
POLB P06746 1/20 0.52
CRHBP P24387 1/20 0.52
CRHR2 Q13324 1/20 0.52
LMNA P02545 1/20 0.51
SLC6A2 P23975 1/20 0.51
KMT2A Q03164 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
SAE1 Q9UBE0 1/20 0.49
UBA2 Q9UBT2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27003088 0.86 SIGMAR1 (0.85) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6422901 0.85 SIGMAR1 (1.00) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6720947 0.85 SIGMAR1 (0.85) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6720810 0.82 SIGMAR1 (0.84) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6512853 0.80 SIGMAR1 (0.72) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6510588 0.79 LMNA (0.50) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6515320 0.78 SIGMAR1 (0.46) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6419685 0.78 SIGMAR1 (1.00) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6720704 0.76 SIGMAR1 (0.86) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6720780 0.76 SIGMAR1 (1.00) SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed